Search Results for "Liquisolids Review"

05:13 EDT 4th October 2015 | BioPortfolio

Matching Channels

Phosphodiesterase 4 PDE 4 Inhibitors

Phosphodiesterase 4 (PDE-4) inhibitors have attracted considerable interest as potential therapeutic agents for diseases including chronic obstructive pulmonary disease. PDE-4 inhibitors are known to ...

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...

Matching News

Peer Review Week: An analysis of peer review style and quality

This week celebrates the first ever Peer Review Week; a collaborative concept from ORCID, Wiley, Sense About Science and ScienceOpen, to highlight and celebrate the invaluable role peer review plays i...

Open peer review could result in better quality of peer review

Whether or not a research article has been peer reviewed openly can seemingly make a difference to the quality of the peer review, according to research carried out by BioMed Central's Research Integr...

Week in Review: August 17?21

Synthetic DNA–based MERS vax shows promise; fake peer review on scores of papers; gut microbes and an autoimmune eye disease; “Informed Consent” theater review

Monsanto Says Panel to Review WHO Finding on Cancer Link to Herbicide

Monsanto Company, the makers of the herbicide Roundup, this week announced that it has arranged for an outside scientific review of the World Health Organization’s finding that the key ingredient in...

AbbVie buys special review voucher for $350 mln

Aug 19 (Reuters) - AbbVie Inc has bought a priority review voucher from United Therapeutics Corp for $350 million that will allow it to accelerate the review process for one of its drugs.

Review of Priority Review Vouchers

This Viewpoint assesses the US Food and Drug Administration’s priority review voucher program to encourage development of drugs to treat neglected tropical diseases or rare pediatric disease and rec...

AbbVie Buys Last Available Priority Review Voucher For $350 Mil.; FDA Ready to Make More

Abbvie is paying $350 million for the right to a faster FDA review for a future application. That means that the value of a priority review voucher has quintupled in the past year.

FDA grants priority review for Novocure’s PMA application of Optune

The US Food and Drug Administration (FDA) has accepted for filing and review as well as granted priority review status for Novocure's premarket approval (PMA) application for Optune.

Matching PubMed Articles

More noise does not mean more precision: A review of Aldenberg and Rorije (2013).

This paper provides a critical review of recently published work that suggests that the precision of hazardous concentration estimates from Species Sensitivity Distributions (SSDs) is improved when th...

Systematic review of coaching to enhance surgeons' operative performance.

There is increasing attention on the coaching of surgeons and trainees to improve performance but no comprehensive review on this topic. The purpose of this review is to summarize the quantity and the...

Book review: Reviewing the review.

Book Review: Review of Pseudohypacusis: False and Exaggerated Hearing Loss.

Review of Small-Bowel Obstruction: The Diagnosis and When to Worry.

This is a review of small-bowel obstruction written primarily for residents. The review focuses on radiography and computed tomography (CT) for diagnosing small-bowel obstruction and CT for determinin...

Search Whole site using Google


Advertisement Advertisement